The Hidden Cost of Running a Vaccine Program
Most practices know what they pay for vaccine inventory. Few know what they’re actually paying to run the program. That’s not a failure of attention. It’s a consequence of a model that was never designed to make the full cost visible. Why? Because vaccines used to be easy. Today, everything around them is complicated. The […]
HEALTH LEADER Q+A: Using AI to boost back-office automation 300%
As a revenue cycle leader, how do you reduce friction, increase efficiency, and speed up cash flow? Mount Sinai Health System did it all — and shared exactly how. Watch Mount Sinai’s VP of Revenue Cycle and Executive Director of IT discuss how the health system used advanced automation and AI to achieve a: 300% […]
The 1-minute recoupment remedy: Use AI to work PLB adjustments 80% faster
Calling recoupments a “billion-dollar” problem is a bit misleading. Each year, more than $40 billion in provider revenue is silently recouped by payers. However, AI is the ideal tool to transform recoupment workflows — and it’s already delivering an 80% time savings as teams work each PLB adjustment in under 1 minute. Watch this webinar […]
Journey of a Therapeutic Antibody: From Preclinical to Clinical Proof of Concept Development
This eBook outlines the journey from discovery to clinical proof of concept, offering valuable guidance to help achieve clinical proof of concept and bring innovative treatments to patients.
Your playbook for reducing employee healthcare costs
Rising deductibles, higher out-of-pocket costs, and rapidly increasing healthcare expenses are becoming a defining workforce issue — not because employees lack coverage, but because, increasingly, they can’t afford to use it. With healthcare costs rising at their fastest rate in 15 years, financially stressed employees are delaying care, skipping medications, and avoiding treatment, creating worse […]
Preparing for the next decade in cell therapy
Cell therapy has entered a new era. As autologous therapies continue to demonstrate durable outcomes and emerging modalities, including allogeneic, iPSC and in vivo approaches, expand into new therapeutic areas, sponsors face increasingly complex manufacturing decisions. A robust Chemistry, Manufacturing and Controls (CMC) strategy has become a critical driver of commercial success, influencing scalability, cost, […]
Phase 1 Oncology Clinical Trial Designs
Phase 1 oncology trials are undergoing a major shift. Traditional 3+3 designs no longer meet regulatory expectations for dose optimization or the complexity of next-generation therapies. Sponsors now need richer early dose-finding data, broader dose exploration, and stronger justification for recommended Phase 2 doses.
How AI is Transforming Medical Conference Preparation
This infographic explores how AI can transform traditional conference preparation to work smarter upfront and speed post-event insight generation. Medical conferences are a traditional method for sharing scientific breakthroughs, but pharma teams often struggle with the demands of conference preparation. Then, after the event, there is the job of managing data and insights. AI is […]
Reducing CGT Fill Finish Risk: Ensure Consistent Quality
Cell and gene therapies (CGTs) hold extraordinary promise, but also present unique manufacturing challenges. In particular, fill/finish must occur in a purpose-built, isolated, highly controlled environment to ensure consistent quality in every dose. CGTs with viral vector requirements add more complexity to drug product manufacturing. An expert CDMO can support viral vector CGTs from preclinical […]
Build a Future-Ready Sterile Development Strategy
Early-phase decisions can determine whether a sterile program scales successfully or incurs costly delays. As clinical programs advance, choices regarding formulation, process development and analytical strategies can create unexpected challenges if not made with commercial readiness in mind. This playbook takes a deep dive into how sponsors can build a more future-focused sterile development roadmap […]